{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in SNCA"
        },
        {
          "HGVS": "NM_000340.3:c.92G>C",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "G",
            "alt": "C",
            "position": "92"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation in SNCA"
        }
      ]
    },
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_181801.3:c.6056A>G",
          "cDNA Change": {
            "transcript": "NM_181801.3",
            "ref": "A",
            "alt": "G",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S mutation in LRRK2"
        }
      ]
    },
    {
      "Gene": "GBA",
      "variants": [
        {
          "HGVS": "NM_007261.3:c.1099A>T",
          "cDNA Change": {
            "transcript": "NM_007261.3",
            "ref": "A",
            "alt": "T",
            "position": "1099"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "S",
            "position": "370"
          },
          "Description in input context": "N370S mutation in GBA"
        }
      ]
    },
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_000300.3:c.505C>A",
          "cDNA Change": {
            "transcript": "NM_000300.3",
            "ref": "C",
            "alt": "A",
            "position": "505"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "H",
            "position": "169"
          },
          "Description in input context": "R169H mutation in PARK2"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005121"
  },
  "Experiment Method": [
    {
      "Assay Method": "Behavioral tests in transgenic mice",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "SNCA A53T transgenic mice",
        "Description": "Transgenic mice overexpressing SNCA A53T mutation were used for behavioral testing."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Transgenic mice exhibited increased α-synuclein aggregation and motor deficits compared to wild-type controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent groups of transgenic mice were tested."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No technical replicates explicitly mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type mice served as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transgenic mice served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical Methods": "ANOVA with post-hoc Tukey's test",
      "Thresholds for Normal/Abnormal": {
        "Normal": "Wild-type mice showed no motor deficits (p > 0.05).",
        "Abnormal": "Transgenic mice showed significant motor deficits (p < 0.01)."
      },
      "Approved Assay": "Yes"
    },
    {
      "Assay Method": "Dopamine measurement in SNCA A30P mice",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "SNCA A30P transgenic mice",
        "Description": "Transgenic mice with SNCA A30P mutation were used to measure dopamine levels."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.92G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "SNCA A30P mice showed reduced dopamine levels in the striatum compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five mice per group were tested."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No technical replicates explicitly mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type mice served as positive controls."
      },
      "Basic negative control": {
        "Basic negative控制": "Yes",
        "Description": "Non-transgenic mice served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical Methods": "Student's t-test",
      "Thresholds for Normal/Abnormal": {
        "Normal": "Wild-type mice showed dopamine levels within physiological range (p > 0.05).",
        "Abnormal": "SNCA A30P mice showed significantly reduced dopamine levels (p < 0.01)."
      },
      "Approved Assay": "Yes"
    },
    {
      "Assay Method": "Motor function tests in LRRK2 G2019S mice",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "LRRK2 G2019S transgenic mice",
        "Description": "Transgenic mice with LRRK2 G2019S mutation were tested for motor function."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_181801.3:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2 G2019S mice exhibited impaired motor coordination and increased phosphorylation of α-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Six mice per group were tested."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No technical replicates explicitly mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type mice served as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transgenic mice served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical Methods": "ANOVA with post-hoc Dunnett's test",
      "Thresholds for Normal/Abnormal": {
        "Normal": "Wild-type mice showed normal motor coordination (p > 0.05).",
        "Abnormal": "LRRK2 G2019S mice showed significant motor impairment (p < 0.01)."
      },
      "Approved Assay": "Yes"
    },
    {
      "Assay Method": "α-synuclein accumulation in GBA N370S mice",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "GBA N370S knock-in mice",
        "Description": "GBA N370S knock-in mice were analyzed for α-synuclein accumulation in the brain."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_007261.3:c.1099A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "GBA N370S mice exhibited increased α-synuclein accumulation in the substantia nigra compared to wild-type controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four mice per group were tested."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No technical replicates explicitly mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type mice served as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transgenic mice served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical Methods": "Student's t-test",
      "Thresholds for Normal/Abnormal": {
        "Normal": "Wild-type mice showed no significant α-synuclein accumulation (p > 0.05).",
        "Abnormal": "GBA N370S mice showed significant α-synuclein accumulation (p < 0.01)."
      },
      "Approved Assay": "Yes"
    },
    {
      "Assay Method": "Mitochondrial function analysis in PARK2 R169H mice",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "PARK2 R169H knockout mice",
        "Description": "PARK2 R169H knockout mice were tested for mitochondrial function in dopaminergic neurons."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000300.3:c.505C>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "PARK2 R169H mice showed impaired mitochondrial complex I activity in dopaminergic neurons."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three mice per group were tested."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No technical replicates explicitly mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type mice served as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transgenic mice served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical Methods": "ANOVA with post-hoc Bonferroni correction",
      "Thresholds for Normal/Abnormal": {
        "Normal": "Wild-type mice showed normal mitochondrial complex I activity (p > 0.05).",
        "Abnormal": "PARK2 R169H mice showed significant mitochondrial dysfunction (p < 0.01)."
      },
      "Approved Assay": "Yes"
    }
  ]
}